Combination of paclitaxel, bevacizumab and MEK162 in second line treatment in platinum-relapsing patient derived ovarian cancer xenografts. - Ricci, Francesca; Guffanti, Federica; Damia, Giovanna; Broggini, Massimo (Molecular Cancer, 2017)